Logo

EPA Hires BioFocus DPI for ToxCast Project; Deal Could Be Worth $8.6M

Apr 19, 2007
NEW YORK (GenomeWeb News) — The US Environmental Protection Agency has hired BioFocus DPI to procure chemicals and manage compounds for the agency’s ToxCast program, BioFocus parent company Galapagos said yesterday. 
 
Galapagos said the contract has a total value of as much as €6.3 million ($8.6 million) over up to five years.
 
Under the agreement, BioFocus will “acquire, analyze, store, format and deliver specific compounds” to the EPA at various sites,” the company said.
 
The EPA’s ToxCast program aims to predict toxicity and analyze 200 or more chemicals using genomic analysis, high-throughput screening assays, and cell-based phenotypic assays.   

Breaking News
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.